Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Non-Current Debt: 2015-2020

Historic Non-Current Debt for Outlook Therapeutics (OTLK) over the last 3 years, with Jun 2020 value amounting to $544,924.

  • Outlook Therapeutics' Non-Current Debt rose 766.94% to $544,924 in Q2 2020 from the same period last year, while for Jun 2020 it was $544,924, marking a year-over-year increase of 766.94%. This contributed to the annual value of $50,285 for FY2019, which is 48.94% down from last year.
  • Outlook Therapeutics' Non-Current Debt amounted to $544,924 in Q2 2020, which was up 2,019.58% from $25,709 recorded in Q1 2020.
  • Outlook Therapeutics' Non-Current Debt's 5-year high stood at $13.2 million during Q3 2017, with a 5-year trough of $25,709 in Q1 2020.
  • Over the past 3 years, Outlook Therapeutics' median Non-Current Debt value was $81,010 (recorded in 2018), while the average stood at $122,162.
  • As far as peak fluctuations go, Outlook Therapeutics' Non-Current Debt tumbled by 99.26% in 2018, and later skyrocketed by 766.94% in 2020.
  • Over the past 5 years, Outlook Therapeutics' Non-Current Debt (Quarterly) stood at $191,236 in 2016, then dropped by 24.97% to $143,488 in 2017, then slumped by 39.40% to $86,947 in 2018, then tumbled by 56.28% to $38,011 in 2019, then spiked by 766.94% to $544,924 in 2020.
  • Its Non-Current Debt stands at $544,924 for Q2 2020, versus $25,709 for Q1 2020 and $38,011 for Q4 2019.